Lck inhibitor 2
-
Catalog numberHY-10644
-
PricePlease ask
-
Size5mg
-
-
Alternative_NamesNA
-
CAS944795-06-6
-
MWt335.36
-
FormulaC18H17N5O2
-
Solubility10 mM in DMSO
-
Clinical_InformationNo Development Reported
-
PathwayProtein Tyrosine Kinase/RTK
-
TargetSrc
-
DescriptionTissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
-
Gene target
-
Short nameLck inhibitor 2
-
Alternative namelymphocyte-specific protein tyrosine kinase suppressor 2
-
Alternative to gene targetlymphocyte-specific protein tyrosine kinase, IMD22 and LSK and p56lck and pp58lck and YT16, LCK and IDBG-95667 and ENSG00000182866 and 3932, transferase activity, Cell surfaces, Lck and IDBG-191117 and ENSMUSG00000000409 and 16818, LCK and IDBG-644592 and ENSBTAG00000012695 and 508890
-